
First-line treatment of ovarian cancer FIGO stages IIIB-IV: focus on therapy with bevacizumab - our experience
Author(s) -
Kristina Katić,
Vesna Marija Potočić Matković,
Joško Lešin,
Goran Vujić,
Pavao Planinić,
Ante Ćorušić
Publication year - 2020
Publication title -
libri oncologici
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.189
H-Index - 3
eISSN - 2584-3826
pISSN - 0300-8142
DOI - 10.20471/lo.2019.47.02-03.12
Subject(s) - bevacizumab , medicine , oncology , ovarian cancer , focus (optics) , gynecology , cancer , chemotherapy , physics , optics